In focus
Latest feed
A New Dawn in Lymphoma Treatment: AbbVie's Epkinly Shows Remarkable Promise
A Significant Setback: Arcus Biosciences Halts Key Lung Cancer Trial with Gilead
Keeping Edmonton Moving: The Marathon of Residential Snow Clearing
Unpacking the Data: InflaRx's Continued Deep Dive into Vilobelimab for Pyoderma Gangrenosum
